CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
106 hedge funds and large institutions have $186M invested in Cymabay Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 28 closing their positions.
Holders
106
Holders Change
-12
Holders Change %
-10.17%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
20
Increased
30
Reduced
32
Closed
28
Calls
$801K
Puts
$345K
Net Calls
+$456K
Net Calls Change
+$107K
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$5.76M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$10K |
3 |
![]()
3
Adage Capital Partners
Boston,
Massachusetts
|
$1.48M |
4 |
4
State Street
Boston,
Massachusetts
|
$1.07M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$2.1M |